Construct: ORF ccsbBroadEn_00907

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF003549.1_s300c1, BRDN0000387912
DNA Barcode:
None
Epitope Tag:
None
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
KIR3DL2 (3812)

Vector Information:

Vector Backbone:
pDONR223
Pol II Cassette 1:
n/a
Pol II Cassette 2:
n/a
Selection Marker:
n/a
Visible Reporter:
n/a
Epitope Tag:
n/a

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 3812 KIR3DL2 killer cell immunoglobulin ... NM_006737.4 100% 100%
2 human 3812 KIR3DL2 killer cell immunoglobulin ... NM_001242867.2 96.2% 96.2% 948_949ins51
3 human 3812 KIR3DL2 killer cell immunoglobulin ... XM_011526940.3 92.3% 92% 1000_1001ins105
4 human 3811 KIR3DL1 killer cell immunoglobulin ... NM_013289.2 90.9% 83.5% (many diffs)
5 human 3811 KIR3DL1 killer cell immunoglobulin ... NM_001322168.1 90.7% 83.2% (many diffs)
6 human 115653 KIR3DL3 killer cell immunoglobulin ... NM_153443.4 79.2% 70.5% (many diffs)
7 human 3813 KIR3DS1 killer cell immunoglobulin ... NM_001083539.2 77.4% 68.7% (many diffs)
8 human 112268355 LOC112268355 killer cell immunoglobulin-... NM_001368254.1 77.4% 68.7% (many diffs)
9 human 3812 KIR3DL2 killer cell immunoglobulin ... XM_017026784.2 74.7% 73.4% (many diffs)
10 human 3811 KIR3DL1 killer cell immunoglobulin ... XM_017030274.1 71.3% 53.5% (many diffs)
11 human 3803 KIR2DL2 killer cell immunoglobulin ... NM_014219.2 70.2% 64.6% (many diffs)
12 human 3802 KIR2DL1 killer cell immunoglobulin ... NM_014218.3 70.1% 63.9% (many diffs)
13 human 112267881 LOC112267881 killer cell immunoglobulin-... NM_001368251.1 69.9% 63.5% (many diffs)
14 human 3804 KIR2DL3 killer cell immunoglobulin ... NM_015868.3 69.1% 63.7% (many diffs)
15 human 100132285 KIR2DS2 killer cell immunoglobulin ... NM_001291695.1 68.2% 62.6% (many diffs)
16 human 57292 KIR2DL5A killer cell immunoglobulin ... NM_020535.3 65.1% 54.6% (many diffs)
17 human 553128 KIR2DL5B killer cell immunoglobulin ... NM_001018081.1 64.6% 53.6% (many diffs)
18 human 3805 KIR2DL4 killer cell immunoglobulin ... NM_002255.6 63.7% 53.6% (many diffs)
19 human 112268354 LOC112268354 killer cell immunoglobulin-... NM_001368253.1 63.7% 53.4% (many diffs)
20 human 100132285 KIR2DS2 killer cell immunoglobulin ... NM_012312.4 61.2% 56.4% (many diffs)
21 human 100132285 KIR2DS2 killer cell immunoglobulin ... XM_017030275.2 61.2% 56.4% (many diffs)
22 human 3806 KIR2DS1 killer cell immunoglobulin ... NM_014512.1 60.8% 55.3% (many diffs)
23 human 3809 KIR2DS4 killer cell immunoglobulin ... NM_012314.6 60.6% 55.8% (many diffs)
24 human 3806 KIR2DS1 killer cell immunoglobulin ... XM_011547998.2 60.6% 55.1% (many diffs)
25 human 3810 KIR2DS5 killer cell immunoglobulin ... NM_014513.2 60.4% 54.5% (many diffs)
26 human 102725023 LOC102725023 killer cell immunoglobulin-... NM_001360171.1 60.4% 54.5% (many diffs)
27 human 3808 KIR2DS3 killer cell immunoglobulin ... NM_012313.1 60.2% 54.2% (many diffs)
28 human 3802 KIR2DL1 killer cell immunoglobulin ... XM_017026782.1 59% 53.6% (many diffs)
29 human 3813 KIR3DS1 killer cell immunoglobulin ... NM_001282170.1 58% 51.4% (many diffs)
30 human 100132285 KIR2DS2 killer cell immunoglobulin ... NM_001291701.1 57.9% 53.6% (many diffs)
31 human 3805 KIR2DL4 killer cell immunoglobulin ... NM_001080770.2 57.6% 48.6% (many diffs)
32 human 3813 KIR3DS1 killer cell immunoglobulin ... NM_001282171.1 55.7% 47.8% (many diffs)
33 human 3806 KIR2DS1 killer cell immunoglobulin ... XM_024452542.1 55.6% 46.3% (many diffs)
34 human 3805 KIR2DL4 killer cell immunoglobulin ... NM_001080772.2 50.6% 43.5% (many diffs)
35 human 3806 KIR2DS1 killer cell immunoglobulin ... XM_024452543.1 49.5% 44.8% (many diffs)
36 human 3806 KIR2DS1 killer cell immunoglobulin ... XM_024452544.1 49.5% 44.8% (many diffs)
37 human 3806 KIR2DS1 killer cell immunoglobulin ... XM_024452545.1 49.5% 44.8% (many diffs)
38 human 3802 KIR2DL1 killer cell immunoglobulin ... XM_017026783.1 49% 43.7% (many diffs)
39 human 3809 KIR2DS4 killer cell immunoglobulin ... NM_001281971.2 47.9% 30.9% (many diffs)
40 human 3806 KIR2DS1 killer cell immunoglobulin ... XM_017030286.1 47% 41.3% (many diffs)
41 human 3802 KIR2DL1 killer cell immunoglobulin ... XM_011526939.2 46.9% 41% (many diffs)
42 human 3809 KIR2DS4 killer cell immunoglobulin ... NM_001281972.2 44.6% 32.4% (many diffs)
43 human 100132285 KIR2DS2 killer cell immunoglobulin ... NM_001291696.1 39.9% 34.9% (many diffs)
44 human 107987438 LOC107987438 uncharacterized LOC107987438 XR_001756645.1 23% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
69
ORF end:
1434
ORF length:
1365
Sequence:
1gttcgttgca acaaattgat gagcaatgct tttttataat gccaacttTG TACAAAAAAG
61TTGGCACCAT GTCGCTCACG GTCGTCAGCA TGGCGTGCGT TGGGTTCTTC TTGCTGCAGG
121GGGCCTGGCC ACTCATGGGT GGTCAGGACA AACCCTTCCT GTCTGCCCGG CCCAGCACTG
181TGGTGCCTCG AGGAGGACAC GTGGCTCTTC AGTGTCACTA TCGTCGTGGG TTTAACAATT
241TCATGCTGTA CAAAGAAGAC AGAAGCCACG TTCCCATCTT CCACGGCAGA ATATTCCAGG
301AGAGCTTCAT CATGGGCCCT GTGACCCCAG CACATGCAGG GACCTACAGA TGTCGGGGTT
361CACGCCCACA CTCCCTCACT GGGTGGTCGG CACCCAGCAA CCCCCTGGTG ATCATGGTCA
421CAGGAAACCA CAGAAAACCT TCCCTCCTGG CCCACCCAGG GCCCCTGCTG AAATCAGGAG
481AGACAGTCAT CCTGCAATGT TGGTCAGATG TCATGTTTGA GCACTTCTTT CTGCACAGAG
541AGGGGATCTC TGAGGACCCC TCACGCCTCG TTGGACAGAT CCATGATGGG GTCTCCAAGG
601CCAACTTCTC CATCGGTCCC TTGATGCCTG TCCTTGCAGG AACCTACAGA TGTTATGGTT
661CTGTTCCTCA CTCCCCCTAT CAGTTGTCAG CTCCCAGTGA CCCCCTGGAC ATCGTGATCA
721CAGGTCTATA TGAGAAACCT TCTCTCTCAG CCCAGCCGGG CCCCACGGTT CAGGCAGGAG
781AGAACGTGAC CTTGTCCTGT AGCTCCTGGA GCTCCTATGA CATCTACCAT CTGTCCAGGG
841AAGGGGAGGC CCATGAACGT AGGCTCCGTG CAGTGCCCAA GGTCAACAGA ACATTCCAGG
901CAGACTTTCC TCTGGGCCCT GCCACCCACG GAGGGACCTA CAGATGCTTC GGCTCTTTCC
961GTGCCCTGCC CTGCGTGTGG TCAAACTCAA GTGACCCACT GCTTGTTTCT GTCACAGGAA
1021ACCCTTCAAG TAGTTGGCCT TCACCCACAG AACCAAGCTC CAAATCTGGT ATCTGCAGAC
1081ACCTGCATGT TCTGATTGGG ACCTCAGTGG TCATCTTCCT CTTCATCCTC CTCCTCTTCT
1141TTCTCCTTTA TCGCTGGTGC TCCAACAAAA AGAATGCTGC TGTAATGGAC CAAGAGCCTG
1201CGGGGGACAG AACAGTGAAT AGGCAGGACT CTGATGAACA AGACCCTCAG GAGGTGACGT
1261ACGCACAGTT GGATCACTGC GTTTTCATAC AGAGAAAAAT CAGTCGCCCT TCTCAGAGGC
1321CCAAGACACC CCTAACAGAT ACCAGCGTGT ACACGGAACT TCCAAATGCT GAGCCCAGAT
1381CCAAAGTTGT CTCCTGCCCA CGAGCACCAC AGTCAGGTCT TGAGGGGGTT TTCTTGCCAA
1441CTTTCTTGTA CAAAGTtggc attataagaa agcattgctt atcaatttgt tgcaacgaac

Download FASTA (ORF) (Full)

GPP Web Portal Terms of Service

Effective Date: December 8, 2025
By using this site, you agree to our terms and conditions below.

Overview of Terms

The data made available on this website were generated for research purposes and are not intended for clinical or commercial uses. Commercial use (or other use for profit-making purposes) of the GPP Web Portal and its tools, is not permitted under these terms and may require a separate license agreement from Broad or its contributors. For more information, please contact partnering@broadinstitute.org.

The original data may be subject to rights claimed by third parties, including but not limited to, patent, copyright, other intellectual property rights, biodiversity-related access and benefit-sharing rights. It is the responsibility of users of Broad Institute services to ensure that their use of the data does not infringe any of the rights of such third parties.

Any questions or comments concerning these Terms of Use can be addressed to: legal@broadinstitute.org.

By accessing and viewing this GPP Web Portal, you agree to the following terms and conditions:

Attribution

You agree to acknowledge the Broad Institute (e.g., in publications, services or products) for any of your use of its online services, databases or software in accordance with good scientific practice. You agree to use the acknowledgment wording provided for the relevant tools as indicated on the FAQ for each tool.

Updating the Terms of Use

We reserve the right to update these Terms of Use at any time. When alterations are inevitable, we will attempt to give reasonable notice of any changes by placing a notice on our website, but you may wish to check each time you use the website. The date of the most recent revision will appear on this, the "GPP Web Portal Terms of Use" page. If you do not agree to these changes, please do not continue to use our online services. We will also make available an archived copy of the previous Terms of Use for comparison.

Indemnification and Disclaimer of Warranties

You are using this GPP Web Portal at your own risk, and you hereby agree to hold Broad and its contributors and their trustees, directors, officers, employees, and affiliated investigators harmless for any third party claims which may arise from your use of the GPP Web Portal, the tools available therein, or any portion thereof. Further, you agree to indemnify Broad, its contributors, and its and their trustees, directors, officers, employees, affiliated investigators, students, and affiliates for any loss, costs, claims, damages, or other liabilities arising from any unpermitted commercial or profit-making use you make of the GPP Web Portal. The GPP Web Portal is a research tool and is provided "as is". Broad does not represent that the GPP Web Portal is free of errors or bugs or suitable for any particular tasks.

ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS ARE DISCLAIMED. IN NO EVENT SHALL BROAD OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THE GPP WEB PORTAL, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

Governing Law

The terms and conditions herein shall be construed, governed, interpreted, and applied in accordance with the internal laws of the Commonwealth of Massachusetts, U.S.A. Furthermore, by accessing, downloading, or using the Database, You consent to the personal jurisdiction of, and venue in, the state and federal courts within Massachusetts with respect to Your download or use of the Database.